Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24086483)

1.

Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients.

Liu L, Yuan G, Cheng Z, Zhang G, Liu X, Zhang H.

PLoS One. 2013 Sep 25;8(9):e75259. doi: 10.1371/journal.pone.0075259. eCollection 2013.

2.

Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens.

Zhu X, Li T, Peng S, Ma X, Chen X, Zhang X.

Behav Brain Res. 2010 Jun 19;209(2):281-8. doi: 10.1016/j.bbr.2010.02.005. Epub 2010 Feb 6.

PMID:
20144661
3.

Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.

Vogel M, Pfeifer S, Schaub RT, Grabe HJ, Barnow S, Freyberger HJ, Cascorbi I.

Neuropsychobiology. 2004;50(4):305-10.

PMID:
15539862
4.
5.

Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?

Urhan-Kucuk M, Erdal ME, Ozen ME, Kul S, Herken H.

Mol Biol Rep. 2011 Apr;38(4):2569-72. doi: 10.1007/s11033-010-0396-4. Epub 2010 Nov 26.

PMID:
21110120
6.

High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats.

Rui G, Guangjian Z, Yong W, Jie F, Yanchao C, Xi J, Fen L.

Behav Brain Res. 2013 Jan 15;237:263-9. doi: 10.1016/j.bbr.2012.09.047. Epub 2012 Oct 2.

PMID:
23036843
7.

[Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].

Paweł K, Hauser J, Skibińska M, Szczepankiewicz A, Dmitrzak-Weglarz M, Gorzkowska K, Pawlak J, Czerski PM.

Psychiatr Pol. 2010 May-Jun;44(3):405-13. Polish.

PMID:
20672519
8.

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.

Urigüen L, García-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casadó V, Lluis C, Franco R, García-Sevilla JA, Meana JJ.

Psychopharmacology (Berl). 2009 Oct;206(2):313-24. doi: 10.1007/s00213-009-1608-2. Epub 2009 Aug 4.

PMID:
19652957
9.

Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.

García MG, Puig JG, Torres RJ.

Brain Behav Immun. 2009 Nov;23(8):1125-31. doi: 10.1016/j.bbi.2009.07.006. Epub 2009 Jul 25.

PMID:
19635551
10.

Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.

Lemmer K, Ahnert-Hilger G, Höpfner M, Hoegerle S, Faiss S, Grabowski P, Jockers-Scherübl M, Riecken EO, Zeitz M, Scherübl H.

Life Sci. 2002 Jun 28;71(6):667-78.

PMID:
12072155
11.

Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.

Chiasson K, Daoust B, Levesque D, Martinoli MG.

Neurotox Res. 2006 Aug;10(1):31-42.

PMID:
17000468
12.
13.

Reduced dopamine D3 receptor expression in blood lymphocytes of smokers is negatively correlated with daily number of smoked cigarettes: a peripheral correlate of dopaminergic alterations in smokers.

Czermak C, Lehofer M, Wagner EM, Prietl B, Gorkiewicz G, Lemonis L, Rohrhofer A, Legl T, Schauenstein K, Liebmann PM.

Nicotine Tob Res. 2004 Feb;6(1):49-54.

PMID:
14982687
14.

Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity.

Perl O, Strous RD, Dranikov A, Chen R, Fuchs S.

Neuropsychobiology. 2006;53(2):88-93. Epub 2006 Feb 23.

PMID:
16511340
15.

Rasgrf2 controls dopaminergic adaptations to alcohol in mice.

Easton AC, Rotter A, Lourdusamy A, Desrivières S, Fernández-Medarde A, Biermann T, Fernandes C, Santos E, Kornhuber J, Schumann G, Müller CP.

Brain Res Bull. 2014 Oct;109:143-50. doi: 10.1016/j.brainresbull.2014.10.008. Epub 2014 Oct 22.

PMID:
25454123
16.

Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.

Pinacho R, Villalmanzo N, Roca M, Iniesta R, Monje A, Haro JM, Meana JJ, Ferrer I, Gill G, Ramos B.

J Psychiatr Res. 2013 Jul;47(7):926-34. doi: 10.1016/j.jpsychires.2013.03.004. Epub 2013 Mar 27.

PMID:
23540600
17.

Reduced dopamine D4 receptor mRNA expression in lymphocytes of long-term abstinent alcohol and heroin addicts.

Czermak C, Lehofer M, Wagner EM, Prietl B, Lemonis L, Rohrhofer A, Schauenstein K, Liebmann PM.

Addiction. 2004 Feb;99(2):251-7.

PMID:
14756717
18.

Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex.

Tallerico T, Novak G, Liu IS, Ulpian C, Seeman P.

Brain Res Mol Brain Res. 2001 Mar 5;87(2):160-5.

PMID:
11245917
19.

The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes.

Perl O, Ilani T, Strous RD, Lapidus R, Fuchs S.

FASEB J. 2003 Oct;17(13):1948-50. Epub 2003 Aug 1.

20.

Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.

Rojas P, Ruiz-Sánchez E, Rojas C, Ogren SO.

Neuroscience. 2012 Oct 25;223:246-57. doi: 10.1016/j.neuroscience.2012.08.004. Epub 2012 Aug 9.

PMID:
22885234
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk